Literature DB >> 24610006

[Prevention and conservative therapy of diverticular disease].

E Kruse1, L Leifeld.   

Abstract

Diverticulosis and diverticular disease are a common problem in daily practice and one third of the patients with diverticulosis develop symptoms. Patients with uncomplicated diverticulitis are very often treated with antibiotics. There is growing evidence that antibiotics are not necessary in uncomplicated cases. One problem is the different classification of diverticulitis and diverticular disease. Therefore, it is not easy to compare different studies. The evidence for therapy with antibiotics, mesalamine, probiotics and fibers are initially discussed and secondly therapeutic recommendations are given for the various stages of diverticular disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24610006     DOI: 10.1007/s00104-013-2619-4

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  24 in total

1.  Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study.

Authors:  Antonio Tursi; Giovanni Brandimarte; Gian Marco Giorgetti; Walter Elisei
Journal:  J Clin Gastroenterol       Date:  2006-04       Impact factor: 3.062

2.  SEGMENTATION AND THE LOCALIZATION OF INTRALUMINAL PRESSURES IN THE HUMAN COLON, WITH SPECIAL REFERENCE TO THE PATHOGENESIS OF COLONIC DIVERTICULA.

Authors:  N S PAINTER; S C TRUELOVE; G M ARDRAN; M TUCKEY
Journal:  Gastroenterology       Date:  1965-08       Impact factor: 22.682

Review 3.  Clinical practice. Diverticulitis.

Authors:  Danny O Jacobs
Journal:  N Engl J Med       Date:  2007-11-15       Impact factor: 91.245

4.  Mild colonic diverticulitis can be treated without antibiotics. A case-control study.

Authors:  N de Korte; J Ph Kuyvenhoven; D L van der Peet; R J Felt-Bersma; M A Cuesta; H B A C Stockmann
Journal:  Colorectal Dis       Date:  2012-03       Impact factor: 3.788

5.  Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study.

Authors:  W Kruis; E Meier; M Schumacher; O Mickisch; R Greinwald; R Mueller
Journal:  Aliment Pharmacol Ther       Date:  2013-02-17       Impact factor: 8.171

6.  Crohn's-like reaction in diverticular disease.

Authors:  A Gledhill; M F Dixon
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

Review 7.  New physiopathological and therapeutic approaches to diverticular disease of the colon.

Authors:  Antonio Tursi
Journal:  Expert Opin Pharmacother       Date:  2007-02       Impact factor: 3.889

8.  Body mass index and diverticular disease: a 28-year follow-up study in men.

Authors:  Anders Rosemar; Ulf Angerås; Annika Rosengren
Journal:  Dis Colon Rectum       Date:  2007-12-22       Impact factor: 4.585

9.  Assessment and grading of mucosal inflammation in colonic diverticular disease.

Authors:  Antonio Tursi; Giovanni Brandimarte; Walter Elisei; Gian Marco Giorgetti; Cosimo Damiano Inchingolo; Silvio Danese; Fabio Aiello
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

10.  Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): prospective study of British vegetarians and non-vegetarians.

Authors:  Francesca L Crowe; Paul N Appleby; Naomi E Allen; Timothy J Key
Journal:  BMJ       Date:  2011-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.